An underground market for unlicensed slimming medications is being driven by social media fitness personalities and vendors on communication apps, based on new investigations.
Investigational Drug Acquiring Traction Via Social Media
The experimental drug, which is still in clinical trials, is being promoted by online personalities for its alleged fat-burning properties. Viewers are encouraged to contact these accounts privately for supplier links, while also receiving discount codes.
Active Commerce on Social Networks
Additionally, a robust trade exists on messaging services, where communities with numerous of members share “before and after” images, injection guides and claims of rapid British shipping. Vendors promote the substance there before directing buyers to other platforms for transactions.
Learning About Retatrutide
This medication is an investigational injectable created by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being hailed digitally as the successor to Ozempic.
Medical Professionals Voice Worries
Nevertheless, doctors and chemists have cautions that the distribution of what remains an unapproved drug in the UK is worrisome and could lead to users administering substances of uncertain source.
Several experts said the demand for retatrutide could be linked to the increasing price of licensed weight loss treatments such as Mounjaro.
Regulatory Position and Implementation
Selling retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unapproved drug that cannot be promoted or distributed for personal consumption under the British medical regulations.
Several influencers attempt to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still violate pharmaceutical, advertising, and customer regulations, potentially leading to penalties, legal action or prison.
Service Response and Material Elimination
According to TikTok, the platform has taken down violative content and prohibited associated hashtags and search suggestions. The company stated it was dedicated to keeping the platform safe and investing in enhancing enforcement strategies.
Digital Trading Activities
Investigations also found communities with up to nine thousand members selling the experimental drug using Telegram's integrated search feature, which operates like a online catalog. Entering “retatrutide” immediately displays groups with numerous of users, populated with photos of weight loss, positive reviews and step-by-step instructions for mixing or injecting at residence.
After moments of entering one community, a vendor shared WhatsApp details, where most transactions take place. The vendor provided an instruction manual and guaranteed delivery within two days. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. None inquired about body mass, medical conditions or previous experience.
Product Information and Pricing
Inside these communities, posts display black plastic parcels with Royal Mail labels, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at home with purified liquid, or ready-to-use pens usually sold at 160 pounds for 20 milligrams. When questioned how much time a injector should be used, vendors give contradictory answers varying between a few weeks to “depends on your body”.
Service Moderation and Safety Measures
A spokesperson for the messaging service stated it regularly moderated dangerous material on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Cautions
“People are administering materials they cannot confirm. Although the research behind this drug is valid, these online versions may not contain what they claim,” stated a pharmacy expert, the head of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor linked the increase in demand to current price rises for approved slimming medications such as Mounjaro. “With costs increasing, individuals are turning to social media. But fake treatments are extremely risky. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she said.
Her team has previously seen patients injured by self-injection from unconfirmed suppliers. “We understand the frustration, but buying from messaging apps or communication platforms is taking chances with your well-being,” stated the doctor. “These substances could be impure or improperly measured.”
Producer Position
A representative from Eli Lilly said the substance was in third stage clinical trials and had not been evaluated or approved by any government authority globally. “Therefore at this time no one can market [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a company experimental substance not yet approved … may expose patients to potentially serious medical dangers”.
